Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02413814 · ClinicalTrials.gov registry record · NA

Computerized Anger-Reduction Treatment for Smoking Cessation

A NA study, sponsored by Florida State University.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT02413814 is a NA study that has completed, run by Florida State University. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02413814, a NA study, has completed, sponsored by Florida State University.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

Problematic anger is a strong predictor of failed attempts at smoking cessation. The investigators proposed study seeks to evaluate whether a novel 8-session computerized anger-reduction treatment improves quit rates among smokers. Smokers with elevated trait anger will be administered transdermal nicotine patch therapy and either anger-reduction treatment or a control intervention. They will be assessed throughout treatment and up until three months after a scheduled mid- treatment quit date. The investigators propose to test whether, compared to the control condition, the anger-reduction treatment will lead to: 1) greater reductions in anger and 2) greater abstinence rates at post-cessation and at follow-up assessments. The investigators will also test whether changes in anger-related symptoms account for group differences in abstinence rates.

Interventions

  • BEHAVIORAL Control Condition
  • BEHAVIORAL Anger Reduction Treatment

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2015-04-01
Est. Completion 2019-07-30
Phase NA

Sponsor

Florida State University

219 total trials

What the Registry Record Tells You About NCT02413814

The ClinicalTrials.gov registry entry for NCT02413814 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Control Condition is the first listed.

NCT02413814 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02413814 about?

NCT02413814 is a clinical study titled "Computerized Anger-Reduction Treatment for Smoking Cessation". Problematic anger is a strong predictor of failed attempts at smoking cessation. The investigators proposed study seeks to evaluate whether a novel 8-session computerized anger-reduction treatment improves quit rates among smokers. Smokers with elevated trait anger will be administered transdermal n...

What is the current status of trial NCT02413814?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2015-04-01. Estimated completion is 2019-07-30.

What interventions are being tested in trial NCT02413814?

The interventions under investigation include: Control Condition (BEHAVIORAL), Anger Reduction Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT02413814?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.